Friday, October 12, 2018

14 hours ago - Michael Carome of Public Citizen, an advocacy group, noted that the revision still includes a provision requiring states that sign an MOU to notify the FDA within 3 business days of any complaint relating to a drug product compounded by a pharmacist or pharmacist and distributed outside the state involving a serious .
Post a Comment